(2-(Aminomethyl)phenyl)boronic acid hydrochloride, 95.0%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5,5,5-trifluoropentanoic acid, 98.0%, 250mg

4-((3S,4R)-3-Methyl-1,6-diazaspiro[3.4]octan-6-yl)-7H-pyrrolo[2,3-d]pyrimidine, 95%, 250mg

p-coumaric acid, min. 98%, 10 g, glass packaging

1-(2-Bromo-5-methoxyphenyl)ethanone, 95.0%, 5g

1-[(4-NITROPHENYL)METHYL]-PIPERIDINE, 95.0%, 250mg

Ethyl 4-iodo-5-methyl-1h-pyrazole-3-carboxylate, 97%, 1g

1-CHLORO-6-FLUOROISOQUINOLINE, 95.0%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,4-dimethylpentanoic acid, 95.0%, 500mg

(S)-3-(4-Fluoro-phenylsulfanyl)-pyrrolidine hydrochloride, 95.0%, 500mg

Neu5Ac alpha(2-6) N-Glycan>95.0%(HPLC)1mg

PD 184352, Free Base, 98.0%, 25mg

(4-(Cyclopropylcarbamoyl)phenyl)boronic acid, 95.0%, 1g